LeafBio, Inc. is the commercialization arm of Mapp Biopharmaceutical.
September 17, 2015 - ZMapp™ is Granted Fast Track Status by the FDA
June 10, 2015 - Mapp signs contract with Public Health Agency of Canada.
February 27, 2015 - Mapp Bio Clinical Trials Press Release
February 6, 2015 - LeafBio, Inc. submitted an Investigational New Drug (IND) application for clinical evaluation of ZMapp™ to the Food and Drug Administration (FDA) on February 3, 2015.